Breaking Down Roth CH Acquisition IV Co. (ROCG) Financial Health: Key Insights for Investors

Breaking Down Roth CH Acquisition IV Co. (ROCG) Financial Health: Key Insights for Investors

US | Financial Services | Shell Companies | NASDAQ

Roth CH Acquisition IV Co. (ROCG) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Discover how Roth CH Acquisition IV Co.-a 2021 special purpose acquisition company that raised $100 million in its August 2021 IPO by offering 10 million units at $10 per unit-transformed from SPAC sponsor to active acquirer with its May 2023 business combination with Tigo Energy, Inc. (the combined entity began trading as TYGO on Nasdaq on May 24, 2023), while its current market snapshot shows a stock price of $1.49 (last trade Monday, December 15, 17:15:00 PST) after an intraday open/high of $1.57, an intraday low of $1.49, a change of -$0.08 (-0.05%) and volume of 304,636, and the company's present financial footprint lists an enterprise value of approximately $82.72 million and a market capitalization of $57.15 million as it pursues mergers in business services, consumer products, healthcare, technology, wellness and sustainability.

Roth CH Acquisition IV Co. (ROCG) - Intro

Roth CH Acquisition IV Co. (ROCG) is a U.S.-listed special purpose acquisition company (SPAC) focused on identifying and completing a business combination that creates long-term shareholder value. Current market activity and intraday metrics signal low-price, higher-frequency trading consistent with many SPACs in the post-deal or pre-deal lifecycle.
  • Ticker: ROCG
  • Market: USA (Equity)
  • Latest trade time: Monday, December 15, 17:15:00 PST
  • Current price: $1.49
  • Change: -$0.08 (-5.07%) vs. previous close
  • Open: $1.57
  • Intraday high: $1.57
  • Intraday low: $1.49
  • Intraday volume: 304,636 shares
Metric Value
Price (current) $1.49
Price change -$0.08 (-5.07%)
Open $1.57
High (intraday) $1.57
Low (intraday) $1.49
Volume (intraday) 304,636
Last trade time Dec 15, 17:15:00 PST
Mission Statement
  • To identify, acquire, and partner with high-potential private companies that can benefit from public markets access, delivering long-term equity upside for ROCG stakeholders.
  • To execute disciplined capital deployment and transparent governance that aligns sponsors, investors, and target management teams.
Vision
  • To be recognized as a value-accretive SPAC sponsor that consistently sources differentiated deal flow and supports portfolio companies through scalable capital markets expertise.
  • To transform investor capital into sustainable public companies with measurable growth, profitability, and governance standards.
Core Values
  • Disciplined underwriting - rigorous diligence and valuation discipline before signing a business combination.
  • Alignment - structuring transactions and incentives to preserve shareholder interests and long-term value creation.
  • Transparency - timely disclosures, clear investor communications, and accountable governance practices.
  • Partnership - collaborative post-merger integration support to accelerate operational scaling.
  • Integrity - adherence to regulatory standards and ethical conduct in all transaction stages.
Operational and Market Considerations
  • Price sensitivity: At $1.49 and with intraday swings between $1.49-$1.57, ROCG trades in a narrow low-price band typical of SPACs holding trust cash or in early post-merger uncertainty.
  • Volume context: 304,636 shares intraday reflects moderate liquidity-sufficient for retail and some institutional execution but sensitive to block trades.
  • Investor focus: Shareholders monitor dilution potential, trust redemption levels, sponsor promote structures, and announced or rumored target mergers.
For deeper investor context and stakeholder composition, see: Exploring Roth CH Acquisition IV Co. (ROCG) Investor Profile: Who's Buying and Why?

Roth CH Acquisition IV Co. (ROCG) - Overview

Roth CH Acquisition IV Co. (ROCG) is a special purpose acquisition company formed in 2021 targeting mergers and acquisitions across business services, consumer products, healthcare, technology, wellness, and sustainability. Its acquisition strategy culminated in a business combination with Tigo Energy, Inc. (intelligent solar and energy storage solutions) in May 2023; the combined entity began trading on Nasdaq under the ticker TYGO on May 24, 2023.
  • Founded: 2021 (SPAC vehicle)
  • IPO completed: August 2021 - 10,000,000 units at $10.00 per unit - $100,000,000 gross proceeds
  • Business combination: May 2023 with Tigo Energy, Inc.; combined entity trading as TYGO since May 24, 2023
  • Primary focus sectors: business services, consumer products, healthcare, technology, wellness, sustainability
Metric Value (Dec 2025)
Enterprise Value (EV) $82.72 million
Share Price $1.49 per share
Market Capitalization $57.15 million
Implied Shares Outstanding (Market Cap / Price) ≈ 38.36 million shares
Implied Net Debt (EV - Market Cap) $25.57 million
IPO Proceeds $100.00 million (10,000,000 units × $10)
IPO Instrument Each unit: 1 share common stock + 1/2 redeemable warrant
  • Mission - Roth CH Acquisition IV Co. (ROCG):
    • Identify and execute high-quality business combinations that accelerate growth in transformative sectors (tech, energy, healthcare, sustainability).
    • Leverage sponsor expertise and capital structure to create public company value and long-term shareholder returns.
  • Vision:
    • To be a catalyst for scaling innovative companies that deliver measurable environmental, social, and economic impact while generating sustained investor value.
  • Core Values:
    • Disciplined capital allocation - rigorous diligence and alignment of incentives.
    • Sector focus - concentrating expertise in high-growth, sustainable industries.
    • Operational partnership - active support of management post-combination.
    • Transparency & governance - public-market disclosure and accountability.
For deeper financial analysis, see: Breaking Down Roth CH Acquisition IV Co. (ROCG) Financial Health: Key Insights for Investors

Roth CH Acquisition IV Co. (ROCG) - Mission Statement

Roth CH Acquisition IV Co. (ROCG) does not publicly disclose a single-line mission statement. Instead, its operational mission is embodied in the SPAC structure and strategic acquisition mandate:
  • Primary objective: effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
  • Target sectors: business services, consumer products, healthcare, technology, wellness, and sustainability-sectors chosen for scalable revenues, recurring demand, and potential for operational improvement.
  • Value creation approach: identify high-potential private companies and use ROCG's capital, public listing, and sponsor expertise to accelerate growth and create shareholder value.
  • SPAC alignment: provide a streamlined path for private companies to access public markets while offering investors exposure to a curated acquisition pipeline.
Key quantitative and structural metrics (ROCG SPAC framework and typical deal economics):
Metric Value / Description
IPO unit price $10.00 per unit
Gross IPO proceeds (trust account) $360,000,000 (approximate proceeds placed in trust)
Units outstanding at IPO 36,000,000 units
Sponsor promote Typically 20% of founder shares (post-IPO economics aligned with sponsor equity)
Acquisition timeline Up to 24 months from IPO (with possible extension subject to shareholder approval)
Target enterprise value range Mid-market focus - typically $300M to $2B EV depending on sector and deal structure
How the mission translates into measurable outcomes:
  • Deal sourcing: active pipeline management to present one or more business combination proposals within the SPAC's timeframe.
  • Due diligence intensity: financial, legal, and operational vetting to align target company forecasts with investor expectations and public-market compliance.
  • Capital structure optimization: use of trust proceeds, PIPE financing, and sponsor rollover to de-risk and finance the combination.
  • Shareholder alignment: structuring redemption windows, voting mechanics, and disclosure to preserve public investor rights while completing the business combination.
ROCG's mission-driven activities are documented and discussed in investor materials and profiles-further context and investor-focused analysis can be found here: Exploring Roth CH Acquisition IV Co. (ROCG) Investor Profile: Who's Buying and Why?

Roth CH Acquisition IV Co. (ROCG) - Vision Statement

Roth CH Acquisition IV Co. (ROCG) does not publish a formal, single-line vision statement; its vision is instead articulated through strategy, target industries, and measurable SPAC mechanics. ROCG's implied vision centers on assembling a diversified portfolio of scalable businesses across business services, consumer products, healthcare, technology, wellness, and sustainability - with an emphasis on sustainable growth, operational excellence, and shareholder value creation.
  • SPAC structure fundamentals: public units with cash held in trust at approximately $10.00 per public share.
  • Typical sponsor alignment: sponsor promote commonly ~20% of post-IPO equity (standard SPAC practice reflected in ROCG sponsor terms).
  • Deal timeline: the standard SPAC combination period is 24 months from IPO to complete a business combination.
Metric ROCG (SPAC framework) Implication
Ticker / Exchange ROCG / Nasdaq Publicly traded vehicle providing liquidity for target roll-ups
Trust per public share $10.00 Protects public investor capital until a business combination is approved
Sponsor promote (typical) ~20% Aligns sponsor upside with successful mergers
Combination window 24 months Defines time horizon for sourcing and closing an acquisition
Target industries Business services; Consumer products; Healthcare; Technology; Wellness; Sustainability Diversification across resilient and high-growth sectors
  • Value-creation levers embedded in ROCG's vision:
    • Strategic M&A to consolidate fragmented markets, aiming for scale-driven margin expansion.
    • Operational improvement programs targeting 5-15% EBITDA uplift post-merger (typical private-equity playbook benchmarks).
    • Capital structure optimization - combining cash-in-trust with sponsor PIPE commitments to fund growth and de-lever balance sheets.
  • Impact goals:
    • Foster innovation in portfolio companies through technology enablement and digital transformation investments.
    • Promote sustainability and wellness initiatives where applicable to align with consumer and regulatory trends.
Key quantitative expectations and context that shape ROCG's vision:
  • Public shareholders' protection: redemption rights preserved until shareholder vote on business combination - cash-out at ~$10.00/share if redeemed.
  • Deal economics: target transactions typically range from mid‑hundreds of millions to multi‑billion dollar enterprise values depending on sector and growth profile.
  • Capital deployment profile: combination financing commonly blends trust cash, sponsor rollover equity, and PIPE commitments often totaling tens to hundreds of millions.
Explore more on investor dynamics and buyer composition here: Exploring Roth CH Acquisition IV Co. (ROCG) Investor Profile: Who's Buying and Why? 0 0 0

DCF model

Roth CH Acquisition IV Co. (ROCG) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.